Table 1.
Level of evidencea | Confidence in the evidence | |
---|---|---|
High | Data derived from meta-analyses or systematic reviews or from (multiple) randomized trials with high quality. | Further research is unlikely to change our confidence in the estimate of benefit and risk. |
Moderate | Data derived from a single randomised controlled trail or multiple non-randomized studies. | Further research (if performed) is likely to have an impact on our confidence in the estimate of benefit and risk and may change the estimate. |
Low | Small studies, retrospective observational studies, registries. | Any estimate of effect is uncertain. |
Recommendations – Gradeb | Wording associated with the grade of recommendation | |
Strong | ‘must’, ‘‘should’ or ‘‘INASL recommends’ | |
Weak | ‘can’, ‘may’ or ‘‘INASL suggests’ |
Level was graded down if there is a poor quality, strong bias or inconsistency between studies; level was graded up if there is a large effect size.
Recommendations were reached by consensus of the panel and included the quality of evidence, presumed patient important outcomes and costs.